Sectoral Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sectoral Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34,000	Closed	-$3.41M	–	83
2025 Q3	$3.41M	Buy	+34,000	New	+$3.06M	2.1%	16
2024 Q1	–	Sell	-20,439	Closed	-$1.82M	–	110
2023 Q4	$1.82M	Sell	20,439 -4,236	-17%	-$315K	0.79%	51
2023 Q3	$1.8M	Buy	24,675 +6,643	+37%	+$531K	0.35%	86
2023 Q2	$1.5M	Sell	18,032 -25,321	-58%	-$2.12M	0.25%	99
2023 Q1	$3.3M	Buy	43,353 +27,871	+180%	+$2.31M	0.64%	66
2022 Q4	$1.29M	Buy	+15,482	New	+$1.25M	0.25%	92

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Sectoral Asset Management's XBI Position: Q4 2025 in Review

Sectoral Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 34,000 shares — an estimated $3.41M sold.

Sectoral Asset Management first reported a position in XBI in Q4 2022 and held it in 6 quarters. The position peaked at $3.41M in Q3 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Sectoral Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Sectoral Asset Management sold 34,000 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $3.41M.
Sectoral Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 6 quarters.
Sectoral Asset Management's State Street SPDR S&P Biotech ETF position peaked at $3.41M in Q3 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Sectoral Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.